Jean-Jacques Bienaim
2011
In 2011, Jean-Jacques Bienaim earned a total compensation of $19.2M as Chief Executive Officer at BioMarin Pharmaceutical, a 255% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $749,721 |
|---|---|
| Option Awards | $3,628,880 |
| Salary | $781,953 |
| Stock Awards | $13,997,640 |
| Other | $22,703 |
| Total | $19,180,897 |
Bienaim received $14M in stock awards, accounting for 73% of the total pay in 2011.
Bienaim also received $749.7K in non-equity incentive plan, $3.6M in option awards, $782K in salary and $22.7K in other compensation.
Rankings
In 2011, Jean-Jacques Bienaim's compensation ranked 85th out of 10,747 executives tracked by ExecPay. In other words, Bienaim earned more than 99.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 85 out of 10,747 | 99th |
Division Manufacturing | 27 out of 3,958 | 99th |
Major group Chemicals And Allied Products | 8 out of 1,031 | 99th |
Industry group Drugs | 5 out of 779 | 99th |
Industry Pharmaceutical Preparations | 5 out of 567 | 99th |
Source: SEC filing on April 21, 2014.
Bienaim's colleagues
We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2011.
2011
Henry Fuchs
BioMarin Pharmaceutical
Chief Medical Officer
2011
Stephen Aselage
BioMarin Pharmaceutical
Executive Vice President & Chief Business Officer
2011
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2011
Jeffrey Cooper
BioMarin Pharmaceutical
Chief Financial Officer
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019